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A commentary on
The carrier effect in the secondary
response to hapten-protein conjugates.
II. cellular cooperation
by Mitchison NA. Eur J Immunol (1971) 1:
18–27. doi:10.1002/ eji.1830010103
The carrier effect in the secondary
response to hapten-protein conjugates.
I. Measurement of the effect with trans-
ferred cells and objections to the local
environment hypothesis
by Mitchison NA. Eur J Immunol (1971) 1:
10–7. doi:10.1002/ eji.1830010204
Until the mid-twentieth century, immu-
nology had been very much a matter of
soluble antibodies and their effect on the
antigens of bacteria and viruses. Then, in
the wartime and post-war years, a new
area opened, of cell-mediated immunity,
driven initially by interest in the ubiq-
uitous rejection of homografts in man
and animals. Experimental tolerance was a
key discovery, that introducing donor-type
cells before the ability to reject homografts
had developed could prevent the rejec-
tion. Hašek in Czechoslovakia made the
discovery independently in 1953 and by
Billingham, Brent, and Medawar in Britain
in 1954.
Proof that rejection of homografts is
immunological in nature came from the
discovery by the Medawar group that skin
grafts are rejected more rapidly if the host
has already rejected previous grafts from
the same donor. My contribution was to
show that this accelerated reaction could
be transferred from one inbred mouse to
another by means of spleen cells (1), work
that I later continued in the laboratory of
George Snell at Bar Harbor, ME (2).
Returning to UK, and after a period
in Edinburgh University, I joined the
National Institute of Medical Research,
where Medawar had become director. My
experience in Edinburgh with chicken ery-
throcytes had taught me the value of
radioactive labeling (3), so I sought to
adapt this technology (fairly new at the
time) to tracking serum antibody levels
in the small blood samples available in
mouse studies. Down the passage worked
Rosalind Pitt-Rivers, discoverer of the thy-
roid hormone T3, a great friend. Jointly
we designed NIP-CAP, a structure related
to T3 that can (i) serve as a powerful
hapten because of its nitro and hydroxyl
groups, (ii) couple smoothly to proteins
to form part of immunogenic molecule,
and (iii) can be prepared in radioactive
form at the iodine residue and thus be
used to assay binding of NI131P-CAP to
its antibody (4). Together these properties
opened the way to an easy mouse serology;
indeed for a while, it became so widely used
that the European Journal of Immunology
accepted its name as not requiring further
explanation.
My work focused on an aspect of
immunological memory, the carrier effect.
An individual primed by injection of a
hapten–protein conjugate makes a full sec-
ondary anti-hapten antibody response only
to the same conjugate, but not to the
same hapten conjugated to another pro-
tein. This finding suggested to us that two
cells might be involved, one recognizing
the hapten and the other the carrier pro-
tein. To explore this possibility, we devised
a serology applicable in mice (5). The small
samples of serum available were appro-
priately diluted and then incubated with
10−8 M NI131P-CAP; their immunoglob-
ulin was then precipitated by addition
of ammonium sulfate solution and cen-
trifuged, carrying the bound radioactive
hapten down with it. By this method, anti-
NIP antibody could be detected down to
a concentration of ~10−9 M, as available
with adoptively transferred spleen cells.
This transfer system could then be used
to explore the carrier effect as defined
above. The secondary response obtained
from the transferred spleen cells was indeed
much reduced (~1000-fold) when the cells
were stimulated with the same hapten
(NIP) attached to a different carrier pro-
tein such as bovine serum albumin, com-
pared to stimulation with the NIP-chicken
γ-globulin originally used to immunize
the cell donor. Importantly, the transferred
anti-NIP response could be inhibited by
injecting an excess of carrier protein, indi-
cating that the carrier protein was itself
recognized independently of the hapten
that it carried, and thus that a second
population of reactive cells was involved
independent of those that recognized the
hapten.
Our experimental design took spleen
cells from mice immunized with NIP-OA
(NIP conjugated with ovalbumin) plus
adjuvant and transferred them into irra-
diated host mice that were then chal-
lenged with either NIP-BSA (NIP conju-
gated to bovine serum albumin) or NIP-
OA (NIP conjugated to ovalbumin), both
without adjuvant. The molar concentra-
tion anti-NIP antibody made in response
was then measured, and its level titrated
against the quantity of antigen in the
challenge. Typically, mice needed a higher
dose of the heterologous antigen (NIP-
BSA) than of the homologous one (NIP-
OA) to achieve the same level of anti-
NIP antibody. Adding spleen cells from
mice immunized with BSA alone to the
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transferred cell population increased sen-
sitivity to NIP-BSA 10–100-fold, a find-
ing that defines the “carrier effect.” The
effect is specific, as the increase was not
obtained with spleen cells from mice
immunized with HSA (human serum albu-
min). These BSA-primed cells did not
contribute directly to the anti-NIP anti-
body, as judged by allotype markers on
the antibody; they acted only as “helper
cells.”
Thus, these findings reveal a carrier
effect mediated by the immune system,
but not by antibody. To test for a T
cell-mediated effect, cells were obtained
from the spleen of mice that 7 days earlier
had been irradiated and then reconstituted
intravenously with 90× 106 syngeneic thy-
mus cells and immunized with BSA, alum,
and pertussis (6). These cells were tested for
helper activity by transfer into irradiated
syngeneic hosts, along with the usual NIP-
BSA as immunogen. The transfer signifi-
cantly increased the host anti-NIP antibody
response, in proportion to the number of
BSA-primed cells transferred.
Such experiments became easier later,
when T cells could be manipulated by
means of anti-theta antibody [reviewed
by Raff (7, 8)]. By then, it had become
clear that cooperation between T and B
cells as revealed by the 1971 study con-
sidered here, most likely works through
an antigen bridge between epitope-specific
receptors on both cells. B cells, with
their immunoglobulin receptors, recog-
nizing the matrix of epitopes presented
on the surface of T cells, became
and remain the accepted mechanism
of T–B cooperation in the immune
response.
T cells and their interactions with
other cells have become a major theme
in immunology. Th interactions lie at the
heart of inflammation and other aspects
of immunological and infectious disease,
and are increasingly being manipulated via
monoclonal antibodies directed at cell sur-
face markers and via cytokines. Advances in
the molecular biology of the cell underpin
these developments. These are extremely
active fields, with much to offer in mol-
ecular cell biology and via therapeutic
intervention.
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